CNERChina New Energy Group Co.

About China New Energy Group Co. (CNER)

China New Energy Group Co. (CNER) is a Diagnostics & Research company headquartered in Spokane, WA, United States whose shares trade over-the-counter on the Pink tier.

China New Energy Group Company ("CNER") bioDrone™, a licensed technology, is a pioneering biotechnology operating at the convergence of AI, quantum sensing, and synthetic biology. Our core platform is a first-in-class molecular defense system designed to detect, trap, and neutralize pathogens—including viruses, bacteria, and toxins—before they can infect humans. Using AI-driven protein modeling, we recreate the exact binding domains that pathogens use to attach to human cells. These synthetic “molecular traps” are engineered to lure pathogens into binding. Upon contact, a quantum energy transfer is triggered, destroying both the pathogen and the trap itself—functioning like a self-sacrificing suicide drone at the molecular level. bioDrone™ operates across multiple environments—air, water, surfaces, and biological fluids—offering a proactive and deployable shield against natural and engineered biological threats. Already in early-stage deployment within select U.S. federal agencies and EU military units, bioDrone™ is aligned with government biodefense priorities. The company is discussing with government agencies worldwide to scale its countermeasure systems for national defense use. As global health threats rise and new pandemics loom, bioDrone™ represents the future of autonomous, intelligent biodefense

Products and services

CNER, utilizing its bioDrone™ license, offers a revolutionary suite of products and services built on a proprietary quantum biosensor platform that detects and neutralizes biological threats at the molecular level. Our core technology uses AI-modeled protein domains to design synthetic receptor traps that mimic human cell targets. When a virus, bacteria, or toxin binds to these traps, a quantum energy transfer is triggered—instantly destroying the pathogen and the synthetic molecule, functioning as a molecular “suicide drone.” Our flagship products include: • bioDrone Surface: A deployable sensor system for high-risk environments—detecting pathogens on contact surfaces in hospitals, airports, and public infrastructure. • bioDrone Air & Water: Environmental biosensing units for pathogen surveillance in HVAC systems, public water supplies, and cleanrooms. • bioDrone LabKit: A modular diagnostic platform for clinical and field labs, enabling real-time detection and neutralization of threats in biological samples. • bioDrone Inside™: An advanced R&D platform under development for in vivo applications to neutralize pathogens within the human body. Requires FDA approval. Services include biosecurity consulting, custom sensor deployment, early-warning system integration, and strategic partnerships with defense, public health, and infrastructure agencies. bioDrone™ is transforming detection into defense—delivering real-time, autonomous biodefense for a changing world.

CNER key facts

Ticker symbol

CNER

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Spokane, WA, United States

Country of incorporation

US

Year of incorporation

2024

Employees

5

Estimated market cap

$38.18M (as of Apr 17, 2025)

Shares outstanding

7,342,532,492

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

China New Energy Group Co. leadership

• Gary Robert Bartholomew — CEO

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with C